STOCK TITAN
  1. Home
  2. Sec-filings
  3. PTNM
  4. [6-K] Pitanium Ltd Current Report (Foreign Issuer)

Pitanium Limited (Nasdaq: PTNM) receives Nasdaq delisting determination notice

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
6-K

Rhea-AI Filing Summary

Pitanium Limited, a Hong Kong-based skincare and personal care retailer, reports that it received a Nasdaq delisting determination letter dated July 7, 2026. The notice follows an October 3, 2025 SEC order suspending trading in the company’s securities, which cited potential manipulation concerns involving recommendations by unknown persons via social media.

Unless Pitanium requests an appeal by July 14, 2026, Nasdaq plans to suspend trading at the opening on July 16, 2026 and subsequently file Form 25-NSE to remove the securities from listing and registration. The company states that Nasdaq has not communicated any findings that Pitanium engaged in wrongdoing, that its operations and financial condition are unaffected, and that its securities may later be eligible for trading on the over-the-counter market, without assurance of an active trading market.

Positive

  • None.

Negative

  • Nasdaq delisting and trading suspension risk: Nasdaq has issued a delisting determination letter and, absent an appeal by July 14, 2026, plans to suspend trading on July 16, 2026 and file Form 25-NSE to remove Pitanium’s securities from Nasdaq, potentially limiting liquidity.
Delisting determination letter date July 7, 2026 Date of Nasdaq Listing Qualifications Staff delisting determination notice to Pitanium
Appeal request deadline July 14, 2026 Last date for Pitanium to request an appeal of Nasdaq’s delisting determination
Planned trading suspension date July 16, 2026 Date Nasdaq will suspend trading if Pitanium does not request an appeal
SEC trading suspension date October 3, 2025 Date the SEC ordered a suspension of trading in Pitanium’s securities
Nasdaq Listing Rule IM-5101-4 regulatory
"has now determined to delist the Company’s securities pursuant to Nasdaq Listing Rule IM-5101-4"
Form 25-NSE regulatory
"Nasdaq will subsequently file a Form 25-NSE with the SEC"
Form 25‑NSE is an official filing used to notify the stock exchange that a company’s securities are being removed from trading on that exchange, similar to handing in a key when a shop closes. Investors care because removal ends public trading on that venue, often cutting liquidity and making it harder to buy or sell shares, which can affect a stock’s price and how quickly investors can access cash or exit positions.
over-the-counter (OTC) market market
"the Company’s securities may be eligible for trading in the over-the-counter (OTC) market"
An over-the-counter (OTC) market is a decentralized way of trading stocks, bonds, or other securities directly between dealers and investors rather than on a formal exchange. It matters to investors because OTC listings often involve smaller, less-regulated companies or specialized securities, which can mean higher risk, lower liquidity, and wider price swings—similar to shopping at a local flea market where selections and prices vary more than at a large supermarket.
forward-looking statements regulatory
"This press release contains forward-looking statements, including statements regarding the impending suspension"
Forward-looking statements are predictions or plans that companies share about what they expect to happen in the future, like estimating sales or profits. They matter because they help investors understand a company's outlook, but since they are based on guesses and assumptions, they can sometimes be wrong.
trading suspension regulatory
"the SEC issued an order suspending trading in the Company’s securities"
A trading suspension is a temporary halt on buying and selling a company's stock imposed by an exchange or regulator while a specific issue is resolved or more information is provided. It matters to investors because it freezes the market value and prevents trades—like pausing a game until the referee clears a disputed play—so investors cannot adjust positions and may face sudden price moves or uncertainty when trading resumes.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Form 6-K: How Foreign Companies Report to the SEC →

FAQ

What did Pitanium Limited (PTNM) announce regarding its Nasdaq listing?
Pitanium announced it received a Nasdaq delisting determination letter dated July 7, 2026. Unless it appeals by July 14, 2026, Nasdaq plans to suspend trading on July 16, 2026 and proceed to delist its securities.

How is the SEC’s prior action connected to Pitanium Limited (PTNM)?
On October 3, 2025, the SEC ordered a suspension of trading in Pitanium’s securities, citing potential manipulation concerns involving recommendations by unknown persons via social media. Nasdaq later halted trading and is now exercising its discretionary delisting authority.

Can Pitanium Limited (PTNM) appeal the Nasdaq delisting determination?
Yes. Pitanium may request an appeal of the Nasdaq delisting determination by July 14, 2026. If it does not do so, Nasdaq plans to suspend trading at the opening on July 16, 2026 and then file Form 25-NSE to remove the listing.

Does the Nasdaq delisting notice claim wrongdoing by Pitanium Limited (PTNM)?
Pitanium states that, to date, Nasdaq has not communicated any findings or determination that the company engaged in wrongdoing related to the recent trading activity or otherwise. The delisting uses Nasdaq’s discretionary authority under Listing Rule IM-5101-4.

What happens to Pitanium Limited (PTNM) shares after Nasdaq delisting?
After Nasdaq files Form 25-NSE, Pitanium’s securities may be eligible for trading on the over-the-counter (OTC) market. The company cautions there is no assurance an active or sustained secondary trading market will develop.

Will the Nasdaq delisting affect Pitanium Limited’s (PTNM) business operations?
Pitanium states the delisting determination does not affect its ongoing business operations or financial condition. The company plans to continue operating in the ordinary course while consulting legal counsel and advisors about next steps.

 

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER

PURSUANT TO RULE 13a-16 OR 15d-16

UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of July 2026

 

Commission File Number: 001-42669

 

PITANIUM LIMITED

(Registrant’s Name)

 

30F, Gravity, 29 Hing Yip Street,

Kwun Tong, Kowloon, Hong Kong

(Address of Principal Executive Offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F.

 

Form 20-F ☒ Form 40-F ☐

 

 

 

 

 

 

INFORMATION CONTAINED IN THIS REPORT ON FORM 6-K

 

On July 10, 2026, Pitanium Limited issued a press release titled “Pitanium Limited Announces Receipt of Nasdaq Delisting Determination Notice.”

 

The press release is furnished herewith as Exhibit 99.1 and is incorporated by reference herein.

 

EXHIBIT INDEX

 

Exhibit No.    
99.1   Press Release Dated July 10, 2026

 

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

Date: July 16, 2026 PITANIUM LIMITED
     
  By: /s/ Ying Yeung Wong
  Name: Ying Yeung Wong
  Title: Chief Executive Officer and Director

 

 

 

 

Exhibit 99.1

 

Pitanium Limited Announces Receipt of Nasdaq Delisting Determination Notice

 

HONG KONG, July 10, 2026 (GLOBE NEWSWIRE) — Pitanium Limited (Nasdaq: PTNM) (“Pitanium” or the “Company”), a Hong Kong-based retailer focused on the sale of proprietary skincare and personal care products, today announced that it received a delisting determination letter, dated July 7, 2026, from the Listing Qualifications Staff of The Nasdaq Stock Market LLC (“Nasdaq”) notifying the Company that Nasdaq Staff has determined to delist the Company’s securities from Nasdaq.

 

On October 3, 2025, the U.S. Securities and Exchange Commission (the “SEC”) issued an order suspending trading in the Company’s securities because of potential manipulation in the Company’s securities effectuated through recommendations made to investors by unknown persons via social media to purchase the securities of the Company (the SEC’s order can be found at https://www.sec.gov/files/litigation/suspensions/2025/34-104165.pdf). Following this, Nasdaq halted trading in the Company’s securities and has now determined to delist the Company’s securities pursuant to Nasdaq Listing Rule IM-5101-4.

 

Nasdaq Listing Rule 5101 provides Nasdaq with “broad discretionary authority over the initial and continued listing of securities in Nasdaq in order to maintain the quality of and public confidence in its market, to prevent fraudulent and manipulative acts and practices, to promote just and equitable principles of trade, and to protect investors and the public interest.” Listing Rule IM-5101-4 further expands on this authority, allowing Nasdaq “to exercise discretion to delist a company from Nasdaq based on the potential for one or more third parties to engage in misconduct impacting a company’s securities where the SEC has implemented a temporary trading suspension.”

 

Following the Notice, the Company has and will continue to consult with its legal counsel and other advisors to evaluate its next steps and will make further announcements as and when appropriate. Unless the Company requests an appeal of this determination by July 14, 2026, trading of the Company’s securities will be suspended at the opening of business on July 16, 2026. Nasdaq will subsequently file a Form 25-NSE with the SEC, which will remove the Company’s securities from listing and registration on The Nasdaq Stock Market.

 

To date, Nasdaq has not communicated any findings or determination that the Company engaged in wrongdoing in connection with the recent trading activity in the Company’s securities or otherwise. The delisting determination does not affect the Company’s ongoing business operations or financial condition, and the Company will continue to conduct its business in the ordinary course.

 

Following the removal from The Nasdaq Stock Market, the Company’s securities may be eligible for trading in the over-the-counter (OTC) market. However, there can be no assurance that an active or sustained secondary trading market will develop for the Company’s securities.

 

About Pitanium Limited

 

Pitanium Limited, incorporated in the British Virgin Islands, is a retailer in Hong Kong focusing on the sale of its proprietary brand products in the field of beauty and personal care, namely PITANIUM and BIG PI, through online channels and physical retail stores in Hong Kong.

 

Forward-Looking Statements

 

This press release contains forward-looking statements, including statements regarding the impending suspension of trading of the Company’s securities on Nasdaq, the subsequent filing of Form 25-NSE, and the potential eligibility of the Company’s securities for trading in the over-the-counter market. Forward-looking statements are subject to risks and uncertainties that may cause actual results to differ materially from those expressed or implied, including risks related to the cessation of listing on a national exchange, the lack of an active or liquid trading market following suspension, the continued trading halt, and other factors discussed in the Company’s filings with the SEC. The Company undertakes no obligation to update any forward-looking statements except as required by law.

 

For more information, please contact:

 

Pitanium Limited

 

Investor Relations Department

Phone: +852 6297 5255

Email: US@pitanium.com

 

 

 

 

Source: View Original Filing on SEC EDGAR

Filing Exhibits & Attachments

1 document

Press Releases